These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

273 related items for PubMed ID: 21763939

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Antiretroviral chemoprophylaxis: new successes and questions.
    Mayer KH.
    Lancet; 2015 Jun 06; 385(9984):2236-7. PubMed ID: 25769358
    [No Abstract] [Full Text] [Related]

  • 23. Recent availability of two novel, fixed formulations of antiretroviral nucleoside analogues: a 12-month prospective, open-label survey of their practical use and therapeutic perspectives in antiretroviral-naive and -experienced patients.
    Manfredi R, Calza L.
    AIDS Patient Care STDS; 2008 Apr 06; 22(4):279-90. PubMed ID: 18290748
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Oral antiretroviral drugs as public health tools for HIV prevention: global implications for adherence, drug resistance, and the success of HIV treatment programs.
    Gupta RK, Wainberg MA, Brun-Vezinet F, Gatell JM, Albert J, Sönnerborg A, Nachega JB.
    J Infect Dis; 2013 Jun 15; 207 Suppl 2(Suppl 2):S101-6. PubMed ID: 23687287
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Efavirenz + emtricitabine + tenofovir: new combination. HIV infection: do not modify ongoing therapy just to use one less tablet. Better adherence than with separate dosing has not been demonstrated, while reduced efficacy is plausible.
    Prescrire Int; 2009 Jun 15; 18(101):105. PubMed ID: 19637416
    [No Abstract] [Full Text] [Related]

  • 36. Oral antiretroviral chemoprophylaxis: current status.
    Baeten J, Celum C.
    Curr Opin HIV AIDS; 2012 Nov 15; 7(6):514-9. PubMed ID: 22964886
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. A perspective on progress and gaps in HIV prevention science.
    Kiser PF, Mesquita PM, Herold BC.
    AIDS Res Hum Retroviruses; 2012 Nov 15; 28(11):1373-8. PubMed ID: 22966871
    [Abstract] [Full Text] [Related]

  • 39. Many in VOICE trial didn't use provided prevention products.
    AIDS Policy Law; 2015 Mar 15; 30(4):3. PubMed ID: 26094276
    [No Abstract] [Full Text] [Related]

  • 40. Systemic administration of antiretrovirals prior to exposure prevents rectal and intravenous HIV-1 transmission in humanized BLT mice.
    Denton PW, Krisko JF, Powell DA, Mathias M, Kwak YT, Martinez-Torres F, Zou W, Payne DA, Estes JD, Garcia JV.
    PLoS One; 2010 Jan 21; 5(1):e8829. PubMed ID: 20098623
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.